Siemens Healthineers announces implementation of Atellica CI at Mahajan Imaging
(No Ratings Yet)
Loading...
Siemens Healthineers, a global leader in medical diagnostics, has announced its pioneering implementation of the new Atellica CI, independent integrated diagnostic testing analyzer at Mahajan Imaging & Labs, to make patient care more predictable. This state-of-the-art analyzer is designed to significantly enhance patient comfort by providing faster, more accurate results.
The new Atellica CI analyzer is a marvel of medical technology in a compact footprint, capable of analyzing over 200 parameters, covering 20 disease states. The analyzer’s microvolume technology maximizes test yield from a single sample aspiration. This feature is particularly beneficial for pediatric and critical cases where low-volume sample testing is essential. The analyzer’s ability to process critical tests within 14 minutes—compared to the conventional 22 to 40 minutes—sets a new standard for rapid diagnostics.
Additionally, emergency assays can be aspirated in just one minute, with results completed in 10 minutes, further streamlining urgent care. The analyzer features a novel “Enhanced Liver Fibrosis (ELF)” test to augment prognosis of Liver Fibrosis, a huge disease burden in India. In 2015, India contributed to 18.3% of the global Liver health related deaths1, and the ELF test can play a vital role in reducing this burden by early detection of liver disease. Further, the advanced technology excels in performing complex and rare tests, such as preeclampsia screening during gestation, with remarkable precision.
Dr. Harsh Mahajan, Founder & Chief Radiologist of Mahajan Imaging & Labs, expressed his enthusiasm, stating, “Being the first to implement the Atellica CI Analyzer is a significant milestone for us and further strengthens our foray into pathology and integrated diagnostics. Liver disease is now of utmost importance in our country. By combining the ELF test with the High End Ultrasound guided Fibro scan, we can very precisely know the current functional and structural status, and predict the onset of Liver disease, non-invasively. This is an example of how combining medical imaging with laboratory diagnostics can play a pivotal role in decision making and providing better treatment outcomes.”
